software version 12.4 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
software version 12.4
Software Version 12.4, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+version+12%2E4/software+version+12+4+0/10__1186_slash_s43066___023___00243___1-46-8-6
Average 90 stars, based on 1 article reviews
Software Version 12.4, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+version+12%2E4/software+version+12+4+0/10__1186_slash_s43066___023___00243___1-46-8-6
Average 90 stars, based on 1 article reviews
software version 12.4 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake. Article Snippet: Background.. Whether anticoagulants other than unfractionated heparin are able to suppress cardiac PET uptake of 2-deoxy-2-[18F]-fluoro-D-glucose (18F-FDG) is unknown.. Methods. Article Title: CHIBA score: a novel model for predicting 3-month mortality in a cohort of Decompensated Liver Disease (DCLD) Article Snippet: Comparisons of AUROCs were performed by Article Title: Development of an 123 I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease Article Snippet: Article Title: Lower hemoglobin with lower ferritin: It is not just a question of anemia. Article Snippet: Aim .. To study the association between blood hemoglobin concentration (b-hemoglobin) and serum ferritin concentration (s-ferritin) in an ambulant patient population without infl ammation and with normal kidney function.. Methods . Article Title: Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis. Article Snippet: KEYWORDS Liver cirrhosis; Mortality; Survival; Prognosis CLIF-C ACLFs presented an AUROC for predicting 30- and 90-day mortality of 0.684 (95% CI: 0.599--0.770) and 0.666 (95% CI: 0.588--0.744) respectively.. No statistically significant differences were found when compared to traditional models.. For patients without ACLF, CLIF-C ADs had an AUROC for predicting 30- and 90-day mortality of 0.689 (95% CI: 0.614--0.763) and 0.672 (95% CI: 0.624--0.720) respectively. Article Title: Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia. Article Snippet: Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia Corrie Studd,* Georgina Cameron,* Lauren Beswick,* Ross Knight, Christopher Hair, John McNeil, Paul Desmond,* Jarrad Wilson,* Wiliam Connell* and Sally Bell* *St Vincent’s Hospital, Melbourne, Geelong Hospital, Geelong, Monash University, Melbourne, Victoria, and Department of Gastroenterology, Royal Hobart Hospital, Hobart, Tasmania, Australia |